Surgery Partners Q4 revenue up 15.9% to $707.1M; sets 2023 EBITDA guidance >$425M

Surgery Partners, Inc.

2022-FY EPS reported -$0.59 revenue$2,539,300,000

Revenue $707.1M in Q4 (+15.9% YoY); full-year revenue $2.5B (+14.1%).
Net loss attributable to common $23.4M in Q4; full-year net loss $54.6M.
Adjusted EBITDA $120.8M in Q4 (+5.6% YoY); full-year $380.2M (+12.0%).
Days adjusted same-facility revenue +10.7% in Q4; +7.7% for full year.
2023 guidance: revenue >$2.75B, Adjusted EBITDA >$425M; liquidity >$830M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Surgery Partners, Inc. reported full year 2023 results: revenue greater than $2.75 billion. Guidance raised.

Period: full year 2023
Revenue: greater than $2.75 billion
Guidance: raised
Result: guidance update

Exact text from the filing

The Company projects 2023 revenues to be greater than $2.75 billion, and projects 2023 Adjusted EBITDA to be greater than $425 million.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Surgery Partners, Inc. reported financial results for fourth quarter ended December 31, 2022.

Period: fourth quarter ended December 31, 2022
Result: reported results

Exact text from the filing

Revenue for the fourth quarter of 2022 increased 15.9% to $707.1 million from $610.2 million for the fourth quarter of 2021.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Surgery Partners, Inc. reported financial results for fourth quarter ended December 31, 2022.

Period: fourth quarter ended December 31, 2022
Result: reported results

Exact text from the filing

For the fourth quarter of 2022, the Company’s 1 net loss attributable to common stockholders and Adjusted EBITDA were $23.4 million and $120.8 million, respectively, compared to $0.1 million and $114.4 million for the same period last year.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Surgery Partners, Inc. reported financial results for full year ended December 31, 2022.

Period: full year ended December 31, 2022
Result: reported results

Exact text from the filing

Revenue for 2022 increased 14.1% to $2,539.3 million from $2,225.1 million in 2021.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Surgery Partners, Inc. reported financial results for full year ended December 31, 2022.

Period: full year ended December 31, 2022
Result: reported results

Exact text from the filing

For the full year 2022, the Company’s net loss attributable to common stockholders and Adjusted EBITDA was $54.6 million and $380.2 million, respectively, compared to $81.2 million and $339.6 million in 2021.

View on SEC.gov

Browse all earnings releases →

Surgery Partners, Inc. filing history →

Source: SEC EDGAR

accession 0001638833-23-000019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.